Getting To $80 Bil.: PhRMA Expects Mix Of Drug Rebates And Fees In Senate Finance Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
In addition to the announced discount for drugs in the Part D donut hole, PhRMA anticipates the Senate Finance Committee's bipartisan bill will seek rebates and fees from pharmaceutical manufacturers.